| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.69B | -1.9% |
| Cost of Revenue | $2.18B | -1.1% |
| Gross Profit | $506.4M | -5.1% |
| R&D Expense | $39.1M | -13.9% |
| SG&A Expense | $607.1M | -14.2% |
| Operating Income | -$100.7M | +88.9% |
| Pre-tax Income | -$201.8M | +77.1% |
| Income Tax | $24.0M | +203.0% |
| Net Income | -$225.8M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $105.8M | -26.5% |
| Accounts Receivable | $266.5M | -10.8% |
| Current Assets | $517.8M | -16.3% |
| Total Assets | $2.80B | -8.3% |
| Current Liabilities | $766.7M | +0.0% |
| Long-term Debt | $2.75B | -1.4% |
| Total Liabilities | $4.02B | -1.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $151.4M | +279.4% |
| Capital Expenditures | $60.8M | -45.3% |
| Investing Cash Flow | -$58.4M | +32.6% |
| Financing Cash Flow | -$134.6M | -4386.7% |
| Free Cash Flow | $90.6M | +227.2% |
| +73.7% |
| EPS (Basic) | -$0.95 | +75.1% |
| EPS (Diluted) | -$0.95 | +75.1% |
| Stockholders' Equity |
| -$1.22B |
| -21.4% |